Taking 250 mg of magnesium daily for two months raises melatonin and lowers cortisol in people with diabetes, which are hormones that help regulate sleep cycles.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis of RCTs measuring serum melatonin and cortisol before and after magnesium supplementation in diabetic populations would determine whether this hormonal shift is consistent and dose-dependent.
A systematic review and meta-analysis of all double-blind RCTs evaluating magnesium (150–500 mg/day) in adults with type 2 diabetes, reporting pre- and post-intervention serum melatonin and cortisol levels, with standardized ELISA methods and adjustment for baseline HbA1c, BMI, and sleep hygiene.
A double-blind RCT would confirm whether magnesium directly alters melatonin and cortisol secretion independent of placebo or other factors.
A double-blind RCT with 150 diabetic participants randomized to 250 mg magnesium gluconate, 250 mg potassium chloride, magnesium + potassium, or placebo for 8 weeks, with serum melatonin and cortisol measured at 0, 4, and 8 weeks under standardized light/dark conditions and fasting, while controlling for depression and sleep hygiene.
A cohort study would determine whether long-term magnesium intake predicts sustained changes in melatonin and cortisol rhythms over time in diabetic individuals.
A prospective cohort study following 500 diabetic adults for 2 years, measuring dietary magnesium intake quarterly and serum melatonin/cortisol levels semi-annually, with actigraphy to assess sleep-wake cycles and adjustment for medication and mental health.
A case-control study would determine whether diabetic patients with low melatonin levels have significantly lower magnesium intake or serum levels than those with normal melatonin.
A case-control study comparing serum magnesium and melatonin levels in 100 diabetic patients with low melatonin (<15 pg/mL) and 100 with normal melatonin (>25 pg/mL), matched for age, sex, HbA1c, and sleep duration.
A cross-sectional study would identify whether serum magnesium levels correlate with melatonin and cortisol concentrations in diabetic patients at a single time point.
A cross-sectional analysis of 800 diabetic patients measuring serum magnesium, melatonin, and cortisol levels in a single visit under standardized conditions, with adjustment for BMI, HbA1c, and time of blood draw.